ENTERO HEALTHCARE SOLU L (ENTERO) financials

ENTERO HEALTHCARE SOLU L (ENTERO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2018, Entero HealthcareSolutions Ltd is in the business of distributionand marketing of pharmaceutical and surgical products and allied services[1]

Market Cap: ₹6,898Cr.
Current Price: ₹1,585
Stock P/E: 330
ROE: 1.75%
ROCE: 2.19%
Book Value: ₹387
Dividend Yield: 0.00%
52W High / Low: ₹1,920/944

In Jun 2026, ENTERO HEALTHCARE SOLU L (ENTERO) reported sales ₹83.27 Cr and net profit ₹3.46 Cr.

Annual TTM: sales ₹352 Cr, net profit ₹23 Cr.

Shareholding: Promoters 52.40% (Jun 2026), FIIs 4.36% (Jun 2026), DIIs 15.48% (Jun 2026), Public 27.77% (Jun 2026), No. of Shareholders 39,709% (Jun 2026).

ENTERO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	112.83	101.15	72.30	79.35	83.22	106.74	78.93	83.27
Expenses	118.90	111.63	84.23	93.06	95.81	120.62	101.47	92.97
Operating Profit	-6.07	-10.48	-11.93	-13.71	-12.59	-13.88	-22.54	-9.70
OPM %	-5.38%	-10.36%	-16.50%	-17.28%	-15.13%	-13.00%	-28.56%	-11.65%
Other Income	28.81	27.51	-21.21	26.29	24.23	18.75	39.96	23.15
Interest	0.39	0.37	0.35	0.59	0.71	0.70	2.60	5.74
Depreciation	2.13	2.19	2.16	2.82	3.32	2.80	2.78	3.11
Profit before tax	20.22	14.47	-35.65	9.17	7.61	1.37	12.04	4.60
Tax %	24.18%	25.50%	-22.02%	24.10%	25.10%	41.61%	-11.38%	25.00%
Net Profit	15.33	10.78	-27.81	6.96	5.70	0.81	13.42	3.46
EPS in Rs	3.52	2.48	-6.39	1.60	1.31	0.19	3.08	0.79
Raw PDF	—	—	—	—	—	—	—	—

ENTERO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	56	105	137	178	318	409	348	352
Expenses	73	137	191	222	353	439	411	411
Operating Profit	-17	-32	-54	-44	-34	-30	-63	-59
OPM %	-30%	-30%	-39%	-25%	-11%	-7%	-18%	-17%
Other Income	21	23	27	53	90	67	109	106
Interest	1	2	5	11	22	2	5	10
Depreciation	4	7	9	10	9	9	12	12
Profit before tax	-2	-18	-41	-12	24	27	30	26
Tax %	-0%	-0%	-0%	-0%	-58%	28%	11%	—
Net Profit	-2	-18	-41	-12	38	19	27	23
EPS in Rs	-162.67	-1,811.38	-106.10	-30.31	8.84	4.41	6.18	5.37
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

ENTERO balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.10	0.10	4	4	43	44	44
Reserves	-13	-31	-72	-84	1,583	1,607	1,640
Borrowings	457	540	674	775	18	14	133
Other Liabilities	21	23	47	68	125	139	342
Total Liabilities	466	533	654	764	1,769	1,804	2,158
Fixed Assets	46	50	51	41	34	28	47
CWIP	2	2	0	-0	-0	0	2
Investments	38	39	39	41	41	277	825
Other Assets	380	442	563	682	1,694	1,498	1,283
Total Assets	466	533	654	764	1,769	1,804	2,158

ENTERO cash flows (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-52	-68	-45	-57	-76	-109	-60
Cash from Investing Activity	-167	-7	-69	-58	-763	208	-132
Cash from Financing Activity	178	76	127	91	926	-41	98
Net Cash Flow	-41	0	14	-24	87	58	-94
Free Cash Flow	-75	-75	-47	-57	-77	-111	-75
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	293%	215%	81%	124%	214%	305%	89%

ENTERO shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	52.44%	52.44%	52.42%	52.42%	52.42%	52.42%	52.42%	52.40%
FIIs	23.82%	22.20%	19.92%	17.21%	14.68%	5.14%	4.03%	4.36%
DIIs	7.73%	8.78%	9.63%	10.19%	9.64%	16.42%	16.62%	15.48%
Public	16.02%	16.59%	18.03%	20.19%	23.26%	26.03%	26.94%	27.77%
No. of Shareholders	36,767	33,172	33,159	33,338	36,334	40,333	39,084	39,709

ENTERO key ratios
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	114	107	139	153	130	89	108
Inventory Days	206	177	103	68	65	110	85
Days Payable	101	48	99	132	88	87	87
Cash Conversion Cycle	219	236	143	89	107	112	107
Working Capital Days	2,013	1,201	1,034	947	850	432	303
ROCE %	—	-3%	-6%	-0%	4%	5%	2%

ENTEROUpdated 18 Oct 2026, 5:23

Entero Healthcare Solu L

ENTEROUpdated 18 Oct 2026, 5:23

Market Cap

₹6,898Cr.

Current Price

₹1,585

High / Low

₹1,920/944

Stock P/E

330

ROE1.75%

ROCE2.19%

Book Value₹387

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2018, Entero HealthcareSolutions Ltd is in the business of distributionand marketing of pharmaceutical and surgical products and allied services[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	61.2	4.65	68.82	14.76	2.41	0.08	-2837.5	2.36	5.74
Sep 2023	73.81	7.32	83	16.52	2.29	-2.28	-6.14	-2.14	-1.33
Dec 2023	76.59	4.73	85.09	16.25	2.32	0.7	-35.71	0.95	0.59
Mar 2024	106.56	5.61	115.75	42.4	1.73	25.87	-44.11	37.28	8.57
Jun 2024	122.38	0.41	124.23	32.17	2.17	27.74	24.77	20.88	4.8
Sep 2024	112.83	0.39	118.9	28.81	2.13	20.22	24.18	15.33	3.52
Dec 2024	101.15	0.37	111.63	27.51	2.19	14.47	25.5	10.78	2.48
Mar 2025	72.3	0.35	84.23	-21.21	2.16	-35.65	-22.02	-27.81	-6.39
Jun 2025	79.35	0.59	93.06	26.29	2.82	9.17	24.1	6.96	1.6
Sep 2025	83.22	0.71	95.81	24.23	3.32	7.61	25.1	5.7	1.31
Dec 2025	106.74	0.7	120.62	18.75	2.8	1.37	41.61	0.81	0.19
Mar 2026	78.93	2.6	101.47	39.96	2.78	12.04	-11.38	13.42	3.08
Jun 2026	83.27	5.74	92.97	23.15	3.11	4.6	25	3.46	0.79

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2020	56	1	73	21	4	-2	0	-2	-162.67
Mar 2021	105	2	137	23	7	-18	0	-18	-1811.38
Mar 2022	137	5	191	27	9	-41	0	-41	-106.1
Mar 2023	178	11	222	53	10	-12	0	-12	-30.31
Mar 2024	318	22	353	90	9	24	-58	38	8.84
Mar 2025	409	2	439	67	9	27	28	19	4.41
Mar 2026	348	5	411	109	12	30	11	27	6.18
TTM	352	10	411	106	12	26	—	23	5.37

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	52.4%
FIIs	4.36%
DIIs	15.48%
Public	27.77%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Mar 2024	52.44%	23.3%	2.28%	21.99%
Jun 2024	52.44%	23.32%	2.06%	22.18%
Sep 2024	52.44%	23.82%	7.73%	16.02%
Dec 2024	52.44%	22.2%	8.78%	16.59%
Mar 2025	52.42%	19.92%	9.63%	18.03%
Jun 2025	52.42%	17.21%	10.19%	20.19%
Sep 2025	52.42%	14.68%	9.64%	23.26%
Dec 2025	52.42%	5.14%	16.42%	26.03%
Mar 2026	52.42%	4.03%	16.62%	26.94%
Jun 2026	52.4%	4.36%	15.48%	27.77%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2020	0.1	-13	457	21	466	46	2	38	380	466
Mar 2021	0.1	-31	540	23	533	50	2	39	442	533
Mar 2022	4	-72	674	47	654	51	0	39	563	654
Mar 2023	4	-84	775	68	764	41	0	41	682	764
Mar 2024	43	1583	18	125	1769	34	0	41	1694	1769
Mar 2025	44	1607	14	139	1804	28	0	277	1498	1804
Mar 2026	44	1640	133	342	2158	47	2	825	1283	2158

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2020	-52	-167	178	-41
Mar 2021	-68	-7	76	0
Mar 2022	-45	-69	127	14
Mar 2023	-57	-58	91	-24
Mar 2024	-76	-763	926	87
Mar 2025	-109	208	-41	58
Mar 2026	-60	-132	98	-94

Key ratios

Historical financial ratios

Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	114	107	139	153	130	89	108
Inventory Days	206	177	103	68	65	110	85
Days Payable	101	48	99	132	88	87	87
Cash Conversion Cycle	219	236	143	89	107	112	107
Working Capital Days	2,013	1,201	1,034	947	850	432	303
ROCE %	—	-3%	-6%	-0%	4%	5%	2%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ENTERO HEALTHCARE SOLU L (ENTERO)?

The reported market capitalisation for ENTERO HEALTHCARE SOLU L (ENTERO) is ₹6,898Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ENTERO?

The current price shown for ENTERO HEALTHCARE SOLU L (ENTERO) on Fincrux is ₹1,585 with a 52-week high/low of ₹1,920/944.

What is the P/E ratio of ENTERO HEALTHCARE SOLU L (ENTERO)?

The stock P/E for ENTERO HEALTHCARE SOLU L (ENTERO) is 330 on Fincrux, with ROE at 1.75% and ROCE at 2.19%.

What were ENTERO latest quarterly results?

For Jun 2026, ENTERO HEALTHCARE SOLU L (ENTERO) reported sales ₹83.27 Cr and net profit ₹3.46 Cr (figures in ₹ crore unless noted).

What are ENTERO annual sales and net profit?

For TTM, ENTERO HEALTHCARE SOLU L (ENTERO) shows sales of ₹352 Cr and net profit of ₹23 Cr on the Fincrux profit & loss statement.

Who owns ENTERO HEALTHCARE SOLU L (ENTERO)?

Latest shareholding for ENTERO HEALTHCARE SOLU L (ENTERO) on Fincrux: Promoters 52.40% (Jun 2026), FIIs 4.36% (Jun 2026), DIIs 15.48% (Jun 2026), Public 27.77% (Jun 2026), No. of Shareholders 39,709% (Jun 2026).

Where can I find ENTERO HEALTHCARE SOLU L (ENTERO) financials?

ENTERO HEALTHCARE SOLU L (ENTERO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ENTERO balance sheet and cash flow?

Yes. The ENTERO HEALTHCARE SOLU L (ENTERO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:23